Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST
Company Participants
Kelly Gerra
Christian Henry – President, CEO & Director
James Gibson – Chief Financial Officer
Conference Call Participants
Lauren Timmins – Jefferies LLC, Research Division
Subhalaxmi Nambi – Guggenheim Securities, LLC, Research Division
Douglas Schenkel – Wolfe Research, LLC
Kyle Mikson – Canaccord Genuity Corp., Research Division
David Westenberg – Piper Sandler & Co., Research Division
Jack Meehan – Nephron Research LLC
Daniel Brennan – TD Cowen, Research Division
Mason Carrico – Stephens Inc., Research Division
Presentation
Operator
Good day, and welcome to PacBio’s Fourth Quarter and Full Year 2025 Earnings Conference Call.
[Operator Instructions]
Please note that today’s event is being recorded. I would now like to turn the conference over to Kelly Gerra with Investor Relations. Please go ahead.
Kelly Gerra
Good afternoon, and welcome to PacBio’s Fourth Quarter and Full Year 2025 Earnings Conference Call. Earlier today, we issued a press release outlining the financial results we’ll be discussing on today’s call, a copy of which is available on the Investors section of our website at http://www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website at http://www.sec.gov.
A copy of our earnings presentation is also available on the Investors section of our website. With me today are Christian Henry, President and Chief Executive Officer; and Jim Gibson, Chief Financial Officer. On today’s call, we will make forward-looking statements, including, among others, statements regarding predictions, estimates, expectations and guidance.
You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks and uncertainties that could cause our actual results to differ materially from those projected or discussed.
Please review our SEC filings, including our most recent Form 10-Q and 10-K and our press releases to better understand
